Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a ...
XOMA Royalty (XOMA) has amended its collaboration, originally established in 2006, with Takeda (TAK) through a strategic royalty share ...
US biotech royalty aggregator XOMA Royalty Corp announced it has amended its collaboration, originally established in 2006, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback